← Back
Data updated: Jun 28, 2026
NOSTRUM PHARMS LLC
Generics Pharmaceuticals
NOSTRUM PHARMS LLC is a generic drug manufacturer with 3 FDA-approved products.
1983
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
NOSTRUM PHARMS LLC's Key Drugs
NOSTRUM PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
NOSTRUM PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for NOSTRUM PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
NOSTRUM PHARMS LLC's Therapeutic Areas
Disease areas where NOSTRUM PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
NOSTRUM PHARMS LLC Pipeline Snapshot
Active clinical trials for NOSTRUM PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1983-01-11
- Latest
- 2023-08-09
- Applications
- 3